Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021.

Curtis, Stephanie J; Shah, Abdul W; Ratu, Ana; Wilson, Donald J; Hill, Philip C; Hulcome, Phil; Gaylard, Cathy; Faktaufon, Daniel; Cabemaiwai, Talica; Rabukawaqa, Isireli; Qoriniasi, Tevita; Narayan, Akesh; Nakalevu, Susana; Romakin, Pablo; Tudravu, Jemesa; Fong, James; Walsh, Nick

Curtis, Stephanie J; Shah, Abdul W; Ratu, Ana; Wilson, Donald J; Hill, Philip C; Hulcome, Phil; Gaylard, Cathy; Faktaufon, Daniel; Cabemaiwai, Talica; Rabukawaqa, Isireli; Qoriniasi, Tevita; Narayan, Akesh; Nakalevu, Susana; Romakin, Pablo; Tudravu, Jemesa; Fong, James; Walsh, Nick.

Emerg Infect Dis ; 29(1): 226-228, 2023 01.

Artículo en Inglés | MEDLINE | ID: covidwho-2198456

ABSTRACT

ABSTRACT

During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.

Asunto(s)

COVID-19; Humanos; Fiji/epidemiología; COVID-19/epidemiología; SARS-CoV-2; Estudios Seroepidemiológicos; Anticuerpos Antivirales

Palabras clave

COVID-19; Fiji; Pacific Islands; SARS; SARS-CoV-2; antibodies; coronavirus; coronavirus disease; disease outbreak; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio observacional Tópicos: Variantes Límite: Humanos Idioma: Inglés Revista: Emerg Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google